StockData

Group 1 Automotive vs Penske Automotive

GPI and PAG side by side, both in retail-auto dealers & gasoline stations. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How GPI and PAG compare

Penske Automotive is the larger company, worth 4.5 times as much as Group 1 Automotive ($13.9B against $3.1B).

On earnings, Group 1 Automotive is cheaper: it trades at 8.3× trailing earnings, against 15.5× for Penske Automotive.

Penske Automotive grew revenue faster over the last twelve months (1.4% versus −3.4% for Group 1 Automotive).

Penske Automotive keeps more of each dollar of sales as profit, with a net margin of 2.8% compared with 1.7% at Group 1 Automotive.

Both pay dividends: Group 1 Automotive yields 0.82% and Penske Automotive 2.7%.

Penske Automotive scores higher on the StockData Score (12 against 10 for Group 1 Automotive), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricGPIPAG
Size and price
Market cap$3.1B$13.9B
Share price$260.80$212.12
Change, 1 year−35.5%31.9%
Change, 5 years32.4%89.6%
Beta (5Y)0.750.66
Employees20K28K
StockData Score
Total score1012 (better)
Valuation score3 (better)0
Growth score1 (better)0
Performance score15 (better)
Health score24 (better)
Dividend score33
Valuation
P/E8.3× (better)15.5×
P/S0.1× (better)0.4×
P/B1.0× (better)2.3×
EV/EBITDA7.8× (better)13.5×
P/FCF13.7× (better)28.0×
FCF yield7.3% (better)3.6%
Fair value$286.98$142.78
Margin of safety9.1% (better)−48.6%
Growth
Revenue growth (TTM)−3.4%1.4% (better)
Revenue growth, 5Y average16.3% (better)9.2%
Net income growth (TTM)0.96% (better)−9.7%
EPS growth (TTM)10.6% (better)−8.8%
EPS growth, 5Y average10.2%16.0% (better)
Profitability
Gross margin15.9%16.0% (better)
Operating margin3.6%3.7% (better)
Net margin1.7%2.8% (better)
FCF margin1.0%1.5% (better)
Return on equity12.4%15.5% (better)
Return on invested capital9.5%11.4% (better)
Financial health
Debt / equity1.270.40 (better)
Net debt / EBITDA3.821.91 (better)
Current ratio1.32 (better)0.98
Altman Z-score3.24 (better)3.11
Piotroski F-score56 (better)
Dividends and buybacks
Dividend yield0.82%2.7% (better)
Payout ratio6.8%41.3%
Years of dividend growth55
Dividend growth, 5Y average27.2%43.9% (better)
Buyback yield12.1% (better)0.48%
Shareholder yield13.0% (better)3.1%
Ownership
Held by institutions100%28.2%
Held by insiders18.0%73.3%
Insider net buying, 12 months$187M (better)−$832K
Superinvestors holding1–
Short interest, % of float14.8%14.1%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.